Schedule 13D ownership disclosure

Atea Pharmaceuticals Inc

Common Stock, $0.001 par value per share · CUSIP: 04683R106

Event date: 2025-02-27

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Radoff Family FoundationReported CIK 0001496916

    Shares: 165,000.00 · Class: 0.2%

  • Radoff Bradley LouisReported CIK 0001380585

    Shares: 2,820,000.00 · Class: 3.3%

  • JEC II Associates, LLCReported CIK 0001477326

    Shares: 1,300,000.00 · Class: 1.5%

  • The MOS Trust

    Shares: 100,000.00 · Class: 0.1%

  • MOS PTC, LLC

    Shares: 100,000.00 · Class: 0.1%

  • Torok MichaelReported CIK 0001967237

    Shares: 1,500,000.00 · Class: 1.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000921895-25-000684
Form type
SCHEDULE 13D
Filer
Atea Pharmaceuticals, Inc.
CIK
CIK 1593899
Filed
Mar 04, 2025
Reporting period
Feb 27, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub